chr10-110781660-G-C
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_001134363.3(RBM20):āc.1051G>Cā(p.Asp351His) variant causes a missense change. The variant allele was found at a frequency of 0.000011 in 1,548,412 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D351D) has been classified as Likely benign.
Frequency
Consequence
NM_001134363.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM20 | NM_001134363.3 | c.1051G>C | p.Asp351His | missense_variant | 2/14 | ENST00000369519.4 | NP_001127835.2 | |
RBM20 | XM_017016103.3 | c.886G>C | p.Asp296His | missense_variant | 2/14 | XP_016871592.1 | ||
RBM20 | XM_017016104.3 | c.667G>C | p.Asp223His | missense_variant | 2/14 | XP_016871593.1 | ||
RBM20 | XM_047425116.1 | c.667G>C | p.Asp223His | missense_variant | 2/14 | XP_047281072.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBM20 | ENST00000369519.4 | c.1051G>C | p.Asp351His | missense_variant | 2/14 | 1 | NM_001134363.3 | ENSP00000358532 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000259 AC: 4AN: 154286Hom.: 0 AF XY: 0.0000245 AC XY: 2AN XY: 81600
GnomAD4 exome AF: 0.0000100 AC: 14AN: 1396086Hom.: 0 Cov.: 32 AF XY: 0.0000102 AC XY: 7AN XY: 688066
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 21, 2013 | The Asp351His variant in RBM20 has not been reported in individuals with cardiom yopathy. Computational analyses (biochemical amino acid properties, conservation , AlignGVGD, and PolyPhen2) do not provide strong support for or against an impa ct to the protein. Additional information is needed to fully assess the clinical significance of this variant. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2021 | The p.D351H variant (also known as c.1051G>C), located in coding exon 2 of the RBM20 gene, results from a G to C substitution at nucleotide position 1051. The aspartic acid at codon 351 is replaced by histidine, an amino acid with similar properties. This alteration has been reported in a genetic testing cohort with limited clinical details (Parikh VN et al. Circ Heart Fail, 2019 03;12:e005371). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Dilated cardiomyopathy 1DD Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at